Mumbai-based drugmaker Cipla on Tuesday said it will price ‘Cipremi’, its generic version of Gilead’s remdesivir for use in Covid-19 patients, at less than ₹5,000 per 100mg vial. Hyderabad’s Hetero Labs, which also gained approval to sell a generic version of remdesivir in India, had said it expects to price a similar dose of the treatment at ₹5,000-₹6,000.